AN IMPLANT RELEASING THE GONADOTROPIN HORMONE-RELEASING HORMONE AGONIST HISTRELIN MAINTAINS MEDICAL CASTRATION FOR UP TO 30 MONTHS IN METASTATIC PROSTATE CANCER-Reference-Cited by-同舟云学术

AN IMPLANT RELEASING THE GONADOTROPIN HORMONE-RELEASING HORMONE AGONIST HISTRELIN MAINTAINS MEDICAL CASTRATION FOR UP TO 30 MONTHS IN METASTATIC PROSTATE CANCER

Published:2000-03 Issue:3 Volume:163 Page:838-844
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

CHERTIN BORIS¹,SPITZ IRVING M.¹,LINDENBERG TZINA¹,ALGUR NURIT¹,ZER TAMI¹,KUZMA PETR¹,YOUNG ALFRED J. MOO¹,CATANE RAPHAEL¹,FARKAS AMICUR¹

Affiliation:

1. From the Departments of Urology and Biochemistry, and Institutes of Hormone Research and Oncology, Shaare Zedek Medical Center and Zer Laboratories, Jerusalem, Israel, National Patent Development, New Brunswick, New Jersey, and Center for Biomedical Research, Population Council, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Management of hormone refractory prostate cancer: current standards and future prospects;Oh;J Urol,1998

2. Patients’ choice of treatment in stage D prostate cancer;Cassileth;Urology,1989

3. Management of cancer of the prostate;Catalona;N Engl J Med,1994

4. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma;Crawford;N Engl J Med,1989

5. Current status of combined androgen blockade: optimal therapy for advanced prostate cancer;Crawford;J Clin Endocrinol Metab,1995

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials;Signal Transduction and Targeted Therapy;2022-06-24

2. Extended Use of Histrelin Implant in Pediatric Patients;Transgender Health;2022-02-10

3. Effects of GnRH agonists on testosterone and testosterone‐stimulated parameters for contraception and aggression reduction in male lion‐tailed Macaques ( Macaca silenus );Zoo Biology;2021-07-05

4. Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer;Journal of Urology;2020-09

5. Procedures for the Nurse Practitioner in Urology;The Nurse Practitioner in Urology;2020